Sustainability of costs of novel biologicals: Are we all heading for bankruptcy?

摘要

In November 2019, Karolinska hospital announced plans to cut some 600 medical posts (350 nurses and 250 physicians), in addition to already laying off 550 administrative staff earlier last year, all in an attempt to plug a hole of SEK1.6bn (£128 m; €150 m; $165 m) in the hospital's budget for 2019.1 In Italy, 18 out of 20 regions spent more on healthcare than was budgeted in 2016, while in the UK, NHS' drugs bills were 33.7% higher in 2017 compared to 2010, with an average annual growth rate of 4.1% in the past 3 years.2, 3